Community-Based Interventions to Improve the Control of Non-Communicable Diseases in Underserved Rural Areas in Brazil: A Before-and-After Study

Hypertension and diabetes mellitus are the second and third highest leading causes of disability-adjusted life-years (DALY), respectively, in Brazil. The clinical outcomes of chronic diseases are influenced by various factors. Therefore, there is a need for multifaceted interventions to achieve a de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in pharmacology 2021-04, Vol.12, p.644599-644599
Hauptverfasser: Lemos Macedo, Jéssica Caline, de Carvalho, Vivian Carla Honorato Dos Santos, Cortes, Taciana Borges Andrade, Soares, Daniela Arruda, Mistro, Sóstenes, Kochergin, Clavdia Nicolaevna, Rumel, Davi, Oliveira, Marcio Galvão
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hypertension and diabetes mellitus are the second and third highest leading causes of disability-adjusted life-years (DALY), respectively, in Brazil. The clinical outcomes of chronic diseases are influenced by various factors. Therefore, there is a need for multifaceted interventions to achieve a decrease in the rate of DALY, with a better control of these diseases. To verify whether sustainable long-term interventions, such as health worker training and provision of health education to the patients, contribute to health improvements in patients with hypertension and diabetes from rural communities. Over a 6 month period, educational and medical interventions were provided to optimize the treatment of hypertension and diabetes. Furthermore, blood pressure and glycated hemoglobin (HbA1c) measurements were taken at baseline and after the interventions. The monitored hypertensive patients ( = 276) had a reduction of 13.4 mmHg ( = 0.021) and 5.8 mmHg ( < 0.001) in mean systolic and diastolic blood pressure, respectively. Diabetic patients who were followed-up ( = 71) achieved a 0.55% ( = 0.185) reduction in HbA1c level. The desired blood pressure level (
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2021.644599